Lumature Wealth Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$26.1K Hold
378
0.02% 261
2023
Q1
$28.1K Sell
378
-13
-3% -$1.09K 0.02% 252
2022
Q4
$36.4K Hold
391
0.02% 239
2022
Q3
$37K Sell
391
-50
-11% -$4.95K 0.02% 242
2022
Q2
$41K Sell
441
-327
-43% -$31.9K 0.02% 245
2022
Q1
$78K Hold
768
0.03% 228
2021
Q4
$79K Sell
768
-174
-18% -$16.1K 0.03% 200
2021
Q3
$80K Sell
942
-121
-11% -$10.1K 0.03% 194
2021
Q2
$89K Sell
1,063
-66
-6% -$5.41K 0.04% 184
2021
Q1
$85K Buy
+1,129
New +$82.2K 0.04% 178

Other funds holding CVS

Lumature Wealth Partners's CVS Position: Q2 2023 in Review

Lumature Wealth Partners held its CVS Health (CVS) position steady in Q2 2023 at 378 shares worth $26.1K. The position accounts for 0.02% of the portfolio, ranked #261.

Lumature Wealth Partners first reported a position in CVS in Q1 2021 and has held it in 10 quarters since. The position peaked at $89K in Q2 2021. 2,204 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Lumature Wealth Partners held 378 shares of CVS Health worth $26.1K as of Q2 2023.
  • Lumature Wealth Partners left its CVS Health share count unchanged in Q2 2023.
  • CVS Health made up 0.02% of Lumature Wealth Partners's portfolio in Q2 2023, its #261 holding.
  • Lumature Wealth Partners first reported a position in CVS Health in Q1 2021 and has held it in 10 quarters since.
  • Lumature Wealth Partners's CVS Health position peaked at $89K in Q2 2021.
  • 2,204 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Lumature Wealth Partners's 13F filing for Q2 2023, filed 14 Aug 2023.